Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
233 USD | +3.13% |
|
+9.35% | +0.69% |
15/07 | ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval | MT |
15/07 | Leerink Partners Adjusts Price Target on IQVIA to $267 From $278, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.69% | 42.45B | |
+25.83% | 47.96B | |
+44.98% | 41.47B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B | |
-3.85% | 11.71B |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- Transcript : Quintiles Transnational Holdings Inc. Presents at The JPMorgan 32nd Annual Healthcare Conference, Jan-15-2014 09